Diabetes

Pharmasave pharmacists trained in medication therapy management
VANCOUVER, B.C. -- Pharmasave announced that its pharmacists have been trained to be leaders in providing medication therapy management programs.

This includes reviewing medications for appropriateness, identifying potential problems such as drug interactions, alternative therapies and contraindications and patient counselling on appropriate use.
Product Quest introduces skin care line to improve hospital-to-home transition
DAYTONA BEACH, Fla. - McCord Research in partnership with Product Quest Manufacturing announced Tuesday the launch of its new hospital-grade skin care kits called At Home - Where Healing Happens Skin Care.

The formulas are designed to improve patient outcomes in the home and address specific skin conditions commonly faced by senior patients over the age of 65.

VoicePort expands automated solutions that support patient care

Though VoicePort’s best-known offering is its PharmaPhonetics platform — which provides multichannel, automated and personalized communications to help pharmacies engage with patients — the Rochester, N.Y.-based company has expanded its offerings as the pharmacist’s role has expanded beyond filling prescriptions to helping patients lead healthy lives.
FDA approves Jentadueto XR from Boehringer Ingelheim, Lilly

SILVER SPRING, Md. — The Food and Drug Administration has approved Boehringer Ingelheim and Eli Lilly and Co.’s Jentadueto XR (linagliptin and metformin HCl) tablets, the companies announced Tuesday.

The new drug is indicated as a once-daily adjunctive treatment for Type 2 diabetes and works by increasing hormones that stimulate insulin production in the pancreas and that stimulate the liver to produce less glucose.
Janssen’s Invokamet gets expanded indication from FDA

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday approved an expanded indication for Janssen Pharmaceuticals’ diabetes medication Invokamet (canagliflozin and metformin HCl). The drug has been approved as a first-line treatment for adults with type 2 diabetes who aren’t being treated with either canagliflozin or metformin.
Omnis Health pairs pharmacy and diabetes patient through Embrace Better Care Program

NASHVILLE, Tenn. - Omnis Health recently announced the introduction of the Embrace Better Care Program, a program that will help pharmacy partners create closer, more proactive connections with their customers with diabetes by providing easy, instant access to diabetes educational resources and technology.
Marsh Drugs extends free diabetes medicine program through 2016
Report: Art gallery tackles diabetes’ effect on dental health
iHealth Lab partners with mySugr on meter, diabetes management app compatibility
Software gives diabetes patients more control of glucose levels

Pharmasave pharmacists trained in medication therapy management

Product Quest introduces skin care line to improve hospital-to-home transition

VoicePort expands automated solutions that support patient care

FDA approves Jentadueto XR from Boehringer Ingelheim, Lilly

Janssen’s Invokamet gets expanded indication from FDA

Omnis Health pairs pharmacy and diabetes patient through Embrace Better Care Program

Marsh Drugs extends free diabetes medicine program through 2016

Report: Art gallery tackles diabetes’ effect on dental health

iHealth Lab partners with mySugr on meter, diabetes management app compatibility

Software gives diabetes patients more control of glucose levels